Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,882.00 -31.00 (-1.62%)

Bid:

1,881.00

Ask:

1,882.00

Spread: 1.00 (0.053%)

Market Cap: £75.48b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

LONDON BRIEFING: FTSE 100 up as UK pushes for tariff reprieve

(Alliance News) - Stocks were called to open higher on Tuesday, following claims that trade talks between US President Donald Trump and Chinese Presid...

DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately...

LONDON MARKET OPEN: Stocks mixed as UK house price growth speeds up

(Alliance News) - Stock prices in London opened mixed on Monday, ahead of the UK's manufacturing PMI reading and following the government's announced ...

US FDA accepts new drug application for GSK's liver drug linerixibat

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease...

GSK's linerixibat to be reviewed by US FDA

(Sharecast News) - Drugmaker GSK revealed on Monday that a new drug application for its linerixibat asset had been accepted for review by the US Food ...

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines

(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's ...

GSK, Spero UTI drug trial ends early after meeting target

(Sharecast News) - UK pharma giant GSK and its partner Spero Therapeutics on Wednesday said it had ended a late-stage trial of an experimental drug fo...

GSK ends cUTI trial early as Spero joint product meets efficacy goal

(Alliance News) - GSK PLC on Wednesday said it will stop a late-stage trial early for an investigational oral antibiotic to treat complicated urinary ...